Sort
21,281 grants matching “influenza”
Improving influenza vaccines through wastewater-based macro-scale strain surveillance
$256,575Sarah Jo Kane · Gt Molecular, Llc · R43 · FY2022 · AI
B. subtilis spore-delivered M2e-FP-based mucosal universal influenza vaccines
$256,500Lanying Du · New York Blood Center · R21 · FY2014 · AI
Mousepox in Aged Mice
$256,500Luis J. Sigal · Research Inst Of Fox Chase Can Ctr · R21 · FY2007 · AI
Impact of prior influenza exposures on antibody repertoires to new viral strains
$256,459Scott Eric Hensley · University Of Pennsylvania · R01 · FY2016 · AI
Clinical Core
$256,393R. Sharon Chinthrajah · Stanford University · U19 · FY2025 · AI
Human and Tuberculin CoA Biosynthetic Enzyme Structures
$256,332Tina Izard · St. Jude Children'S Research Hospital · R01 · FY2006 · AI
Universal Influenza DNA vaccine with Novel Toll-Like Receptor Adjuvants
$256,171Kenneth C Bagley · Profectus Biosciences, Inc. · R43 · FY2008 · AI
INTERMEDIATES AND TRANSBILAYER PEPTIDES
$256,033Ohio State University · R01 · FY2001 · GM
Emerging Infectious Diseases: A Museum Exhibition/Program
$256,010Laurie Ann Kleinbaum Fink · Science Museum Of Minnesota · R25 · FY2007 · RR
New BioCascade System for Investigating the Airborne Transmission Modes of Respiratory Viruses
$256,005Arantzazu Eiguren Fernandez · Aerosol Dynamics, Inc. · R43 · FY2021 · AI
SBIR Phase I: Early Diagnosis of the COVID-19 Cytokine Storm via Point-of-Care Antibody Profiling
$256,000Anna Schibel · Electronic Bio Sciences · · FY2020 · TIP
STTR Phase I: Recombinant BCG as a novel immunoadjuvant for viral infections
$256,000Todd Wallach · Oncosting Llc · · FY2022 · TIP
Transient Gene Therapy as Broad Spectrum Antiviral
$255,932Dusan Bogunovic · Lab11 Therapeutics, Llc · R41 · FY2021 · AI
Transgenic Aminal Core
$255,870Jeffrey Victor Ravetch · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI
Integrated Analysis of SARS-CoV-2 Vaccine Responses During Aging
$255,860Peter The Sage · Brigham And Women'S Hospital · R21 · FY2021 · AI
Optimization to Improve the Protective Capacity of the Tp0751 Syphilis Vaccine Candidate
$255,832Caroline E Cameron · University Of Washington · U19 · FY2023 · AI
Regenerative therapy for lung infection by S. pneumoniae
$255,815Hao Shen · University Of Pennsylvania · R21 · FY2017 · AI
Synthesizing the Evolutionary and Ecological Dynamics of Acute RNA Viruses: Compa
$255,806Bryan Grenfell · Princeton University · R01 · FY2011 · GM
Using the Default Effect to Promote Healthy Behavior
$255,767Gretchen B Chapman · Rutgers, The State Univ Of N.J. · R01 · FY2011 · AG
Human Vaccine Durability using Integrated Bioinformatics and a Novel in vitro Bone Marrow Mimic
$255,683Frances Eun-Hyung Lee · Emory University · U01 · FY2022 · AI
SBIR Phase I: IM3UNE: A Platform for Integrated Monitoring, Mapping, Modeling and Understanding of Novel Epidemics Like COVID-19
$255,631Ashlee M Valente · Geometric Data Analytics · · FY2020 · TIP
SBIR Phase I: Machine Learning for Early Detection of COVID-19 Plaques in Cells
$255,571Ilya G Goldberg · Viqi Llc · · FY2020 · TIP
Class II Processing Delineated by Flu Glycoproteins
$255,563Laurence Crane Eisenlohr · Thomas Jefferson University · R01 · FY2008 · AI
Core A - Administrative Core
$255,560Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AI
TH1 AND TH2 RESPONSES IN VIRAL IMMUNITY
$255,518Mount Sinai School Of Medicine Of Nyu · R01 · FY2001 · AI